A detailed history of Covenant Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Covenant Partners, LLC holds 1,001 shares of LLY stock, worth $887,836. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,001
Previous 1,001 -0.0%
Holding current value
$887,836
Previous $778,000 16.45%
% of portfolio
0.28%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$592.2 - $792.28 $1,184 - $1,584
-2 Reduced 0.2%
1,001 $778,000
Q3 2023

Oct 20, 2023

BUY
$434.7 - $599.3 $219,523 - $302,646
505 Added 101.41%
1,003 $538,000
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $174,668 - $233,552
498 New
498 $233,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Covenant Partners, LLC Portfolio

Follow Covenant Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.